Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.19 USD | -0.58% | -1.17% | +3.81% |
May. 08 | Vaxcyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 25 | Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Bullish |
Resistance | 67.52 | 81.05 | 76.87 |
Spread/Res. | -3.45% | -19.57% | -15.19% |
Spread/Supp. | +2.89% | +35.70% | +9.03% |
Support | 63.36 | 48.04 | 59.79 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- PCVX Stock
- Charts Vaxcyte, Inc.